Trial Profile
Prolonged ENoxapariN in primarY percutaneous coronary intervention compared WIth Standard-of-carE therapy: Feasibility study (PENNYWISE Feasibility)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2023
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary) ; Enoxaparin sodium (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms PENNYWISE Feasibility Trial
- 11 Jul 2020 Status changed from recruiting to completed.
- 05 Jul 2018 New trial record